Neil Herskowitz Checkpoint Therapeutics, Inc. (CKPT) insider trading activity

CKPT Quotes by TradingView

Neil Herskowitz is Director of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 134,812 shares of CKPT, which is worth approximately $471,842. The most recent transaction as insider was on Dec 13, 2024, when has been sold 17,638 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135K
15.05% 3M change
283.83% 12M change
Total Value Held $471,842

Neil Herskowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
BUY
Grant, award, or other acquisition
-
17,638 Added 11.57%
134,812 Common Stock
May 14 2024
BUY
Grant, award, or other acquisition
-
82,051 Added 41.19%
117,174 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
17,483 Added 33.23%
35,123 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
47,619 Added 21.26%
176,401 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
16,502 Added 11.36%
128,782 Common Stock

Also insider at

DERM
Journey Medical Corp Healthcare
Director
MBIO
MUSTANG BIO, INC. Healthcare
Director
ATXI
AVENUE THERAPEUTICS, INC. Healthcare
Director
NH

Neil Herskowitz

Director
Scottsdale, AZ

Track Institutional and Insider Activities on CKPT

Follow Checkpoint Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CKPT shares.

Notify only if

Insider Trading

Get notified when an Checkpoint Therapeutics, Inc. insider buys or sells CKPT shares.

Notify only if

News

Receive news related to Checkpoint Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CKPT